Global Liposome Drug Delivery Market Analysis and Forecast 2024-2030
Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, The global Liposome Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Liposome Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposome Drug Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Liposome Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposome Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Liposome Drug Delivery segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Liposome Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, The global Liposome Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Liposome Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposome Drug Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Liposome Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposome Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Liposome Drug Delivery segment by Company
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Liposome Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Liposome Drug Delivery Market by Type
1.2.1 Global Liposome Drug Delivery Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery Market by Application
1.3.1 Global Liposome Drug Delivery Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 LIPOSOME DRUG DELIVERY MARKET DYNAMICS
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Liposome Drug Delivery Revenue Estimates and Forecasts (2019-2030)
3.2 Global Liposome Drug Delivery Revenue by Region
3.2.1 Global Liposome Drug Delivery Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Liposome Drug Delivery Revenue by Region (2019-2024)
3.2.3 Global Liposome Drug Delivery Revenue by Region (2025-2030)
3.2.4 Global Liposome Drug Delivery Revenue Market Share by Region (2019-2030)
3.3 Global Liposome Drug Delivery Sales Estimates and Forecasts 2019-2030
3.4 Global Liposome Drug Delivery Sales by Region
3.4.1 Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Liposome Drug Delivery Sales by Region (2019-2024)
3.4.3 Global Liposome Drug Delivery Sales by Region (2025-2030)
3.4.4 Global Liposome Drug Delivery Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Liposome Drug Delivery Revenue by Manufacturers
4.1.1 Global Liposome Drug Delivery Revenue by Manufacturers (2019-2024)
4.1.2 Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Liposome Drug Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Liposome Drug Delivery Sales by Manufacturers
4.2.1 Global Liposome Drug Delivery Sales by Manufacturers (2019-2024)
4.2.2 Global Liposome Drug Delivery Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Liposome Drug Delivery Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Liposome Drug Delivery Sales Price by Manufacturers (2019-2024)
4.4 Global Liposome Drug Delivery Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Liposome Drug Delivery Manufacturers, Product Type & Application
4.7 Global Liposome Drug Delivery Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Liposome Drug Delivery Market CR5 and HHI
4.8.2 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier
5 LIPOSOME DRUG DELIVERY MARKET BY TYPE
5.1 Global Liposome Drug Delivery Revenue by Type
5.1.1 Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Liposome Drug Delivery Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
5.2 Global Liposome Drug Delivery Sales by Type
5.2.1 Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Liposome Drug Delivery Sales by Type (2019-2030) & (K Vial)
5.2.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
5.3 Global Liposome Drug Delivery Price by Type
6 LIPOSOME DRUG DELIVERY MARKET BY APPLICATION
6.1 Global Liposome Drug Delivery Revenue by Application
6.1.1 Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Liposome Drug Delivery Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
6.2 Global Liposome Drug Delivery Sales by Application
6.2.1 Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Liposome Drug Delivery Sales by Application (2019-2030) & (K Vial)
6.2.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
6.3 Global Liposome Drug Delivery Price by Application
7 COMPANY PROFILES
7.1 Gilead Sciences
7.1.1 Gilead Sciences Comapny Information
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
7.1.5 Gilead Sciences Recent Developments
7.2 Pacira
7.2.1 Pacira Comapny Information
7.2.2 Pacira Business Overview
7.2.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Pacira Liposome Drug Delivery Product Portfolio
7.2.5 Pacira Recent Developments
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Comapny Information
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
7.3.5 Sun Pharmaceutical Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Comapny Information
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
7.4.5 Johnson & Johnson Recent Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Comapny Information
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
7.5.5 Luye Pharma Recent Developments
7.6 Sigma-Tau
7.6.1 Sigma-Tau Comapny Information
7.6.2 Sigma-Tau Business Overview
7.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
7.6.5 Sigma-Tau Recent Developments
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Comapny Information
7.7.2 Ipsen (Onivyde) Business Overview
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
7.7.5 Ipsen (Onivyde) Recent Developments
7.8 CSPC
7.8.1 CSPC Comapny Information
7.8.2 CSPC Business Overview
7.8.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 CSPC Liposome Drug Delivery Product Portfolio
7.8.5 CSPC Recent Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Comapny Information
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
7.9.5 Teva Pharmaceutical Recent Developments
7.10 Novartis
7.10.1 Novartis Comapny Information
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Novartis Liposome Drug Delivery Product Portfolio
7.10.5 Novartis Recent Developments
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Comapny Information
7.11.2 Fudan-Zhangjiang Business Overview
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
7.11.5 Fudan-Zhangjiang Recent Developments
8 NORTH AMERICA
8.1 North America Liposome Drug Delivery Market Size by Type
8.1.1 North America Liposome Drug Delivery Revenue by Type (2019-2030)
8.1.2 North America Liposome Drug Delivery Sales by Type (2019-2030)
8.1.3 North America Liposome Drug Delivery Price by Type (2019-2030)
8.2 North America Liposome Drug Delivery Market Size by Application
8.2.1 North America Liposome Drug Delivery Revenue by Application (2019-2030)
8.2.2 North America Liposome Drug Delivery Sales by Application (2019-2030)
8.2.3 North America Liposome Drug Delivery Price by Application (2019-2030)
8.3 North America Liposome Drug Delivery Market Size by Country
8.3.1 North America Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Liposome Drug Delivery Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Liposome Drug Delivery Market Size by Type
9.1.1 Europe Liposome Drug Delivery Revenue by Type (2019-2030)
9.1.2 Europe Liposome Drug Delivery Sales by Type (2019-2030)
9.1.3 Europe Liposome Drug Delivery Price by Type (2019-2030)
9.2 Europe Liposome Drug Delivery Market Size by Application
9.2.1 Europe Liposome Drug Delivery Revenue by Application (2019-2030)
9.2.2 Europe Liposome Drug Delivery Sales by Application (2019-2030)
9.2.3 Europe Liposome Drug Delivery Price by Application (2019-2030)
9.3 Europe Liposome Drug Delivery Market Size by Country
9.3.1 Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Liposome Drug Delivery Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Liposome Drug Delivery Market Size by Type
10.1.1 China Liposome Drug Delivery Revenue by Type (2019-2030)
10.1.2 China Liposome Drug Delivery Sales by Type (2019-2030)
10.1.3 China Liposome Drug Delivery Price by Type (2019-2030)
10.2 China Liposome Drug Delivery Market Size by Application
10.2.1 China Liposome Drug Delivery Revenue by Application (2019-2030)
10.2.2 China Liposome Drug Delivery Sales by Application (2019-2030)
10.2.3 China Liposome Drug Delivery Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Liposome Drug Delivery Market Size by Type
11.1.1 Asia Liposome Drug Delivery Revenue by Type (2019-2030)
11.1.2 Asia Liposome Drug Delivery Sales by Type (2019-2030)
11.1.3 Asia Liposome Drug Delivery Price by Type (2019-2030)
11.2 Asia Liposome Drug Delivery Market Size by Application
11.2.1 Asia Liposome Drug Delivery Revenue by Application (2019-2030)
11.2.2 Asia Liposome Drug Delivery Sales by Application (2019-2030)
11.2.3 Asia Liposome Drug Delivery Price by Application (2019-2030)
11.3 Asia Liposome Drug Delivery Market Size by Country
11.3.1 Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Liposome Drug Delivery Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Liposome Drug Delivery Market Size by Type
12.1.1 MEALA Liposome Drug Delivery Revenue by Type (2019-2030)
12.1.2 MEALA Liposome Drug Delivery Sales by Type (2019-2030)
12.1.3 MEALA Liposome Drug Delivery Price by Type (2019-2030)
12.2 MEALA Liposome Drug Delivery Market Size by Application
12.2.1 MEALA Liposome Drug Delivery Revenue by Application (2019-2030)
12.2.2 MEALA Liposome Drug Delivery Sales by Application (2019-2030)
12.2.3 MEALA Liposome Drug Delivery Price by Application (2019-2030)
12.3 MEALA Liposome Drug Delivery Market Size by Country
12.3.1 MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Liposome Drug Delivery Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Liposome Drug Delivery Value Chain Analysis
13.1.1 Liposome Drug Delivery Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Liposome Drug Delivery Production Mode & Process
13.2 Liposome Drug Delivery Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Liposome Drug Delivery Distributors
13.2.3 Liposome Drug Delivery Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Liposome Drug Delivery Market by Type
1.2.1 Global Liposome Drug Delivery Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery Market by Application
1.3.1 Global Liposome Drug Delivery Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 LIPOSOME DRUG DELIVERY MARKET DYNAMICS
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Liposome Drug Delivery Revenue Estimates and Forecasts (2019-2030)
3.2 Global Liposome Drug Delivery Revenue by Region
3.2.1 Global Liposome Drug Delivery Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Liposome Drug Delivery Revenue by Region (2019-2024)
3.2.3 Global Liposome Drug Delivery Revenue by Region (2025-2030)
3.2.4 Global Liposome Drug Delivery Revenue Market Share by Region (2019-2030)
3.3 Global Liposome Drug Delivery Sales Estimates and Forecasts 2019-2030
3.4 Global Liposome Drug Delivery Sales by Region
3.4.1 Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Liposome Drug Delivery Sales by Region (2019-2024)
3.4.3 Global Liposome Drug Delivery Sales by Region (2025-2030)
3.4.4 Global Liposome Drug Delivery Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Liposome Drug Delivery Revenue by Manufacturers
4.1.1 Global Liposome Drug Delivery Revenue by Manufacturers (2019-2024)
4.1.2 Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Liposome Drug Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Liposome Drug Delivery Sales by Manufacturers
4.2.1 Global Liposome Drug Delivery Sales by Manufacturers (2019-2024)
4.2.2 Global Liposome Drug Delivery Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Liposome Drug Delivery Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Liposome Drug Delivery Sales Price by Manufacturers (2019-2024)
4.4 Global Liposome Drug Delivery Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Liposome Drug Delivery Manufacturers, Product Type & Application
4.7 Global Liposome Drug Delivery Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Liposome Drug Delivery Market CR5 and HHI
4.8.2 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier
5 LIPOSOME DRUG DELIVERY MARKET BY TYPE
5.1 Global Liposome Drug Delivery Revenue by Type
5.1.1 Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Liposome Drug Delivery Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
5.2 Global Liposome Drug Delivery Sales by Type
5.2.1 Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Liposome Drug Delivery Sales by Type (2019-2030) & (K Vial)
5.2.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
5.3 Global Liposome Drug Delivery Price by Type
6 LIPOSOME DRUG DELIVERY MARKET BY APPLICATION
6.1 Global Liposome Drug Delivery Revenue by Application
6.1.1 Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Liposome Drug Delivery Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
6.2 Global Liposome Drug Delivery Sales by Application
6.2.1 Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Liposome Drug Delivery Sales by Application (2019-2030) & (K Vial)
6.2.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
6.3 Global Liposome Drug Delivery Price by Application
7 COMPANY PROFILES
7.1 Gilead Sciences
7.1.1 Gilead Sciences Comapny Information
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
7.1.5 Gilead Sciences Recent Developments
7.2 Pacira
7.2.1 Pacira Comapny Information
7.2.2 Pacira Business Overview
7.2.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Pacira Liposome Drug Delivery Product Portfolio
7.2.5 Pacira Recent Developments
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Comapny Information
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
7.3.5 Sun Pharmaceutical Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Comapny Information
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
7.4.5 Johnson & Johnson Recent Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Comapny Information
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
7.5.5 Luye Pharma Recent Developments
7.6 Sigma-Tau
7.6.1 Sigma-Tau Comapny Information
7.6.2 Sigma-Tau Business Overview
7.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
7.6.5 Sigma-Tau Recent Developments
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Comapny Information
7.7.2 Ipsen (Onivyde) Business Overview
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
7.7.5 Ipsen (Onivyde) Recent Developments
7.8 CSPC
7.8.1 CSPC Comapny Information
7.8.2 CSPC Business Overview
7.8.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 CSPC Liposome Drug Delivery Product Portfolio
7.8.5 CSPC Recent Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Comapny Information
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
7.9.5 Teva Pharmaceutical Recent Developments
7.10 Novartis
7.10.1 Novartis Comapny Information
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Novartis Liposome Drug Delivery Product Portfolio
7.10.5 Novartis Recent Developments
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Comapny Information
7.11.2 Fudan-Zhangjiang Business Overview
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
7.11.5 Fudan-Zhangjiang Recent Developments
8 NORTH AMERICA
8.1 North America Liposome Drug Delivery Market Size by Type
8.1.1 North America Liposome Drug Delivery Revenue by Type (2019-2030)
8.1.2 North America Liposome Drug Delivery Sales by Type (2019-2030)
8.1.3 North America Liposome Drug Delivery Price by Type (2019-2030)
8.2 North America Liposome Drug Delivery Market Size by Application
8.2.1 North America Liposome Drug Delivery Revenue by Application (2019-2030)
8.2.2 North America Liposome Drug Delivery Sales by Application (2019-2030)
8.2.3 North America Liposome Drug Delivery Price by Application (2019-2030)
8.3 North America Liposome Drug Delivery Market Size by Country
8.3.1 North America Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Liposome Drug Delivery Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Liposome Drug Delivery Market Size by Type
9.1.1 Europe Liposome Drug Delivery Revenue by Type (2019-2030)
9.1.2 Europe Liposome Drug Delivery Sales by Type (2019-2030)
9.1.3 Europe Liposome Drug Delivery Price by Type (2019-2030)
9.2 Europe Liposome Drug Delivery Market Size by Application
9.2.1 Europe Liposome Drug Delivery Revenue by Application (2019-2030)
9.2.2 Europe Liposome Drug Delivery Sales by Application (2019-2030)
9.2.3 Europe Liposome Drug Delivery Price by Application (2019-2030)
9.3 Europe Liposome Drug Delivery Market Size by Country
9.3.1 Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Liposome Drug Delivery Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Liposome Drug Delivery Market Size by Type
10.1.1 China Liposome Drug Delivery Revenue by Type (2019-2030)
10.1.2 China Liposome Drug Delivery Sales by Type (2019-2030)
10.1.3 China Liposome Drug Delivery Price by Type (2019-2030)
10.2 China Liposome Drug Delivery Market Size by Application
10.2.1 China Liposome Drug Delivery Revenue by Application (2019-2030)
10.2.2 China Liposome Drug Delivery Sales by Application (2019-2030)
10.2.3 China Liposome Drug Delivery Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Liposome Drug Delivery Market Size by Type
11.1.1 Asia Liposome Drug Delivery Revenue by Type (2019-2030)
11.1.2 Asia Liposome Drug Delivery Sales by Type (2019-2030)
11.1.3 Asia Liposome Drug Delivery Price by Type (2019-2030)
11.2 Asia Liposome Drug Delivery Market Size by Application
11.2.1 Asia Liposome Drug Delivery Revenue by Application (2019-2030)
11.2.2 Asia Liposome Drug Delivery Sales by Application (2019-2030)
11.2.3 Asia Liposome Drug Delivery Price by Application (2019-2030)
11.3 Asia Liposome Drug Delivery Market Size by Country
11.3.1 Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Liposome Drug Delivery Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Liposome Drug Delivery Market Size by Type
12.1.1 MEALA Liposome Drug Delivery Revenue by Type (2019-2030)
12.1.2 MEALA Liposome Drug Delivery Sales by Type (2019-2030)
12.1.3 MEALA Liposome Drug Delivery Price by Type (2019-2030)
12.2 MEALA Liposome Drug Delivery Market Size by Application
12.2.1 MEALA Liposome Drug Delivery Revenue by Application (2019-2030)
12.2.2 MEALA Liposome Drug Delivery Sales by Application (2019-2030)
12.2.3 MEALA Liposome Drug Delivery Price by Application (2019-2030)
12.3 MEALA Liposome Drug Delivery Market Size by Country
12.3.1 MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Liposome Drug Delivery Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Liposome Drug Delivery Value Chain Analysis
13.1.1 Liposome Drug Delivery Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Liposome Drug Delivery Production Mode & Process
13.2 Liposome Drug Delivery Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Liposome Drug Delivery Distributors
13.2.3 Liposome Drug Delivery Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Liposomal Doxorubicin Major Manufacturers
Table 3. Liposomal Amphoteracin B Major Manufacturers
Table 4. Liposomal Paclitaxel Major Manufacturers
Table 5. Others Major Manufacturers
Table 6. Global Liposome Drug Delivery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Fungal Infection Therapy Major Manufacturers
Table 8. Cancer & Tumor Therapy Major Manufacturers
Table 9. Others Major Manufacturers
Table 10. Liposome Drug Delivery Industry Trends
Table 11. Liposome Drug Delivery Industry Drivers
Table 12. Liposome Drug Delivery Industry Opportunities and Challenges
Table 13. Liposome Drug Delivery Industry Restraints
Table 14. Global Liposome Drug Delivery Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Liposome Drug Delivery Revenue by Region (2019-2024) & (US$ Million)
Table 16. Global Liposome Drug Delivery Revenue by Region (2025-2030) & (US$ Million)
Table 17. Global Liposome Drug Delivery Revenue Market Share by Region (2019-2024)
Table 18. Global Liposome Drug Delivery Revenue Market Share by Region (2025-2030)
Table 19. Global Liposome Drug Delivery Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Vial)
Table 20. Global Liposome Drug Delivery Sales by Region (2019-2024) & (K Vial)
Table 21. Global Liposome Drug Delivery Sales by Region (2025-2030) & (K Vial)
Table 22. Global Liposome Drug Delivery Sales Market Share by Region (2019-2024)
Table 23. Global Liposome Drug Delivery Sales Market Share by Region (2025-2030)
Table 24. Global Liposome Drug Delivery Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
Table 26. Global Liposome Drug Delivery Sales by Manufacturers (US$ Million) & (2019-2024)
Table 27. Global Liposome Drug Delivery Sales Market Share by Manufacturers (2019-2024)
Table 28. Global Liposome Drug Delivery Sales Price (USD/Vial) of Manufacturers (2019-2024)
Table 29. Global Liposome Drug Delivery Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 30. Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
Table 31. Global Liposome Drug Delivery Manufacturers, Product Type & Application
Table 32. Global Liposome Drug Delivery Manufacturers Commercialization Time
Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Liposome Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 35. Global Liposome Drug Delivery Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Liposome Drug Delivery Revenue Market Share by Type (2019-2024)
Table 39. Global Liposome Drug Delivery Revenue Market Share by Type (2025-2030)
Table 40. Global Liposome Drug Delivery Sales by Type 2019 VS 2023 VS 2030 (K Vial)
Table 41. Global Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 42. Global Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 43. Global Liposome Drug Delivery Sales Market Share by Type (2019-2024)
Table 44. Global Liposome Drug Delivery Sales Market Share by Type (2025-2030)
Table 45. Global Liposome Drug Delivery Price by Type (2019-2024) & (USD/Vial)
Table 46. Global Liposome Drug Delivery Price by Type (2025-2030) & (USD/Vial)
Table 47. Global Liposome Drug Delivery Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 49. Global Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 50. Global Liposome Drug Delivery Revenue Market Share by Application (2019-2024)
Table 51. Global Liposome Drug Delivery Revenue Market Share by Application (2025-2030)
Table 52. Global Liposome Drug Delivery Sales by Application 2019 VS 2023 VS 2030 (K Vial)
Table 53. Global Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 54. Global Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 55. Global Liposome Drug Delivery Sales Market Share by Application (2019-2024)
Table 56. Global Liposome Drug Delivery Sales Market Share by Application (2025-2030)
Table 57. Global Liposome Drug Delivery Price by Application (2019-2024) & (USD/Vial)
Table 58. Global Liposome Drug Delivery Price by Application (2025-2030) & (USD/Vial)
Table 59. Gilead Sciences Company Information
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 62. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 63. Gilead Sciences Recent Development
Table 64. Pacira Company Information
Table 65. Pacira Business Overview
Table 66. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 67. Pacira Liposome Drug Delivery Product Portfolio
Table 68. Pacira Recent Development
Table 69. Sun Pharmaceutical Company Information
Table 70. Sun Pharmaceutical Business Overview
Table 71. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 72. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 73. Sun Pharmaceutical Recent Development
Table 74. Johnson & Johnson Company Information
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 77. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 78. Johnson & Johnson Recent Development
Table 79. Luye Pharma Company Information
Table 80. Luye Pharma Business Overview
Table 81. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 82. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 83. Luye Pharma Recent Development
Table 84. Sigma-Tau Company Information
Table 85. Sigma-Tau Business Overview
Table 86. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 87. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 88. Sigma-Tau Recent Development
Table 89. Ipsen (Onivyde) Company Information
Table 90. Ipsen (Onivyde) Business Overview
Table 91. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 92. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 93. Ipsen (Onivyde) Recent Development
Table 94. CSPC Company Information
Table 95. CSPC Business Overview
Table 96. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 97. CSPC Liposome Drug Delivery Product Portfolio
Table 98. CSPC Recent Development
Table 99. Teva Pharmaceutical Company Information
Table 100. Teva Pharmaceutical Business Overview
Table 101. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 102. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 103. Teva Pharmaceutical Recent Development
Table 104. Novartis Company Information
Table 105. Novartis Business Overview
Table 106. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 107. Novartis Liposome Drug Delivery Product Portfolio
Table 108. Novartis Recent Development
Table 109. Fudan-Zhangjiang Company Information
Table 110. Fudan-Zhangjiang Business Overview
Table 111. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 112. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 113. Fudan-Zhangjiang Recent Development
Table 114. North America Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 115. North America Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 116. North America Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 117. North America Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 118. North America Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 119. North America Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 120. North America Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 121. North America Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 122. North America Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 123. North America Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 124. North America Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 125. North America Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 126. North America Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 127. North America Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 128. North America Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 129. North America Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 130. North America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 131. North America Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 132. North America Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 133. North America Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 134. US Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 135. Canada Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 136. Europe Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 137. Europe Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 138. Europe Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 139. Europe Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 140. Europe Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 141. Europe Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 142. Europe Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 143. Europe Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 144. Europe Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 145. Europe Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 146. Europe Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 147. Europe Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 148. Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 149. Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 150. Europe Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 151. Europe Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 152. Europe Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 153. Europe Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 154. Europe Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 155. Europe Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 156. Germany Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 157. France Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 158. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 159. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 160. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 161. China Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 162. China Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 163. China Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 164. China Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 165. China Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 166. China Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 167. China Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 168. China Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 169. China Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 170. China Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 171. China Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 172. China Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 173. Asia Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 174. Asia Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 175. Asia Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 176. Asia Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 177. Asia Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 178. Asia Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 179. Asia Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 180. Asia Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 181. Asia Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 182. Asia Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 183. Asia Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 184. Asia Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 185. Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 186. Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 187. Asia Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 188. Asia Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 189. Asia Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 190. Asia Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 191. Asia Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 192. Asia Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 193. Japan Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 194. South Korea Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 195. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 196. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 197. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 198. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 199. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 200. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 201. MEALA Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 202. MEALA Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 203. MEALA Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 204. MEALA Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 205. MEALA Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 206. MEALA Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 207. MEALA Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 208. MEALA Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 209. MEALA Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 210. MEALA Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 211. MEALA Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 212. MEALA Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 213. MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 214. MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 215. MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 216. MEALA Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 217. MEALA Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 218. MEALA Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 219. MEALA Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 220. MEALA Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 221. Mexico Liposome Dru
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Liposomal Doxorubicin Major Manufacturers
Table 3. Liposomal Amphoteracin B Major Manufacturers
Table 4. Liposomal Paclitaxel Major Manufacturers
Table 5. Others Major Manufacturers
Table 6. Global Liposome Drug Delivery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Fungal Infection Therapy Major Manufacturers
Table 8. Cancer & Tumor Therapy Major Manufacturers
Table 9. Others Major Manufacturers
Table 10. Liposome Drug Delivery Industry Trends
Table 11. Liposome Drug Delivery Industry Drivers
Table 12. Liposome Drug Delivery Industry Opportunities and Challenges
Table 13. Liposome Drug Delivery Industry Restraints
Table 14. Global Liposome Drug Delivery Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Liposome Drug Delivery Revenue by Region (2019-2024) & (US$ Million)
Table 16. Global Liposome Drug Delivery Revenue by Region (2025-2030) & (US$ Million)
Table 17. Global Liposome Drug Delivery Revenue Market Share by Region (2019-2024)
Table 18. Global Liposome Drug Delivery Revenue Market Share by Region (2025-2030)
Table 19. Global Liposome Drug Delivery Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Vial)
Table 20. Global Liposome Drug Delivery Sales by Region (2019-2024) & (K Vial)
Table 21. Global Liposome Drug Delivery Sales by Region (2025-2030) & (K Vial)
Table 22. Global Liposome Drug Delivery Sales Market Share by Region (2019-2024)
Table 23. Global Liposome Drug Delivery Sales Market Share by Region (2025-2030)
Table 24. Global Liposome Drug Delivery Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
Table 26. Global Liposome Drug Delivery Sales by Manufacturers (US$ Million) & (2019-2024)
Table 27. Global Liposome Drug Delivery Sales Market Share by Manufacturers (2019-2024)
Table 28. Global Liposome Drug Delivery Sales Price (USD/Vial) of Manufacturers (2019-2024)
Table 29. Global Liposome Drug Delivery Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 30. Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
Table 31. Global Liposome Drug Delivery Manufacturers, Product Type & Application
Table 32. Global Liposome Drug Delivery Manufacturers Commercialization Time
Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Liposome Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 35. Global Liposome Drug Delivery Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Liposome Drug Delivery Revenue Market Share by Type (2019-2024)
Table 39. Global Liposome Drug Delivery Revenue Market Share by Type (2025-2030)
Table 40. Global Liposome Drug Delivery Sales by Type 2019 VS 2023 VS 2030 (K Vial)
Table 41. Global Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 42. Global Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 43. Global Liposome Drug Delivery Sales Market Share by Type (2019-2024)
Table 44. Global Liposome Drug Delivery Sales Market Share by Type (2025-2030)
Table 45. Global Liposome Drug Delivery Price by Type (2019-2024) & (USD/Vial)
Table 46. Global Liposome Drug Delivery Price by Type (2025-2030) & (USD/Vial)
Table 47. Global Liposome Drug Delivery Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 49. Global Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 50. Global Liposome Drug Delivery Revenue Market Share by Application (2019-2024)
Table 51. Global Liposome Drug Delivery Revenue Market Share by Application (2025-2030)
Table 52. Global Liposome Drug Delivery Sales by Application 2019 VS 2023 VS 2030 (K Vial)
Table 53. Global Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 54. Global Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 55. Global Liposome Drug Delivery Sales Market Share by Application (2019-2024)
Table 56. Global Liposome Drug Delivery Sales Market Share by Application (2025-2030)
Table 57. Global Liposome Drug Delivery Price by Application (2019-2024) & (USD/Vial)
Table 58. Global Liposome Drug Delivery Price by Application (2025-2030) & (USD/Vial)
Table 59. Gilead Sciences Company Information
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 62. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 63. Gilead Sciences Recent Development
Table 64. Pacira Company Information
Table 65. Pacira Business Overview
Table 66. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 67. Pacira Liposome Drug Delivery Product Portfolio
Table 68. Pacira Recent Development
Table 69. Sun Pharmaceutical Company Information
Table 70. Sun Pharmaceutical Business Overview
Table 71. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 72. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 73. Sun Pharmaceutical Recent Development
Table 74. Johnson & Johnson Company Information
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 77. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 78. Johnson & Johnson Recent Development
Table 79. Luye Pharma Company Information
Table 80. Luye Pharma Business Overview
Table 81. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 82. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 83. Luye Pharma Recent Development
Table 84. Sigma-Tau Company Information
Table 85. Sigma-Tau Business Overview
Table 86. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 87. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 88. Sigma-Tau Recent Development
Table 89. Ipsen (Onivyde) Company Information
Table 90. Ipsen (Onivyde) Business Overview
Table 91. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 92. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 93. Ipsen (Onivyde) Recent Development
Table 94. CSPC Company Information
Table 95. CSPC Business Overview
Table 96. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 97. CSPC Liposome Drug Delivery Product Portfolio
Table 98. CSPC Recent Development
Table 99. Teva Pharmaceutical Company Information
Table 100. Teva Pharmaceutical Business Overview
Table 101. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 102. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 103. Teva Pharmaceutical Recent Development
Table 104. Novartis Company Information
Table 105. Novartis Business Overview
Table 106. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 107. Novartis Liposome Drug Delivery Product Portfolio
Table 108. Novartis Recent Development
Table 109. Fudan-Zhangjiang Company Information
Table 110. Fudan-Zhangjiang Business Overview
Table 111. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 112. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 113. Fudan-Zhangjiang Recent Development
Table 114. North America Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 115. North America Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 116. North America Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 117. North America Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 118. North America Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 119. North America Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 120. North America Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 121. North America Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 122. North America Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 123. North America Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 124. North America Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 125. North America Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 126. North America Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 127. North America Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 128. North America Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 129. North America Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 130. North America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 131. North America Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 132. North America Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 133. North America Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 134. US Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 135. Canada Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 136. Europe Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 137. Europe Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 138. Europe Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 139. Europe Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 140. Europe Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 141. Europe Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 142. Europe Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 143. Europe Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 144. Europe Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 145. Europe Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 146. Europe Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 147. Europe Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 148. Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 149. Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 150. Europe Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 151. Europe Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 152. Europe Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 153. Europe Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 154. Europe Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 155. Europe Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 156. Germany Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 157. France Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 158. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 159. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 160. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 161. China Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 162. China Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 163. China Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 164. China Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 165. China Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 166. China Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 167. China Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 168. China Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 169. China Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 170. China Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 171. China Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 172. China Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 173. Asia Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 174. Asia Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 175. Asia Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 176. Asia Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 177. Asia Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 178. Asia Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 179. Asia Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 180. Asia Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 181. Asia Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 182. Asia Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 183. Asia Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 184. Asia Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 185. Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 186. Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 187. Asia Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 188. Asia Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 189. Asia Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 190. Asia Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 191. Asia Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 192. Asia Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 193. Japan Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 194. South Korea Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 195. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 196. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 197. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 198. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 199. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 200. Liposome Drug Delivery Revenue (2019-2030) & (US$ Million)
Table 201. MEALA Liposome Drug Delivery Revenue by Type (2019-2024) & (US$ Million)
Table 202. MEALA Liposome Drug Delivery Revenue by Type (2025-2030) & (US$ Million)
Table 203. MEALA Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 204. MEALA Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 205. MEALA Liposome Drug Delivery Sales Price by Type (2019-2024) & (USD/Vial)
Table 206. MEALA Liposome Drug Delivery Sales Price by Type (2025-2030) & (USD/Vial)
Table 207. MEALA Liposome Drug Delivery Revenue by Application (2019-2024) & (US$ Million)
Table 208. MEALA Liposome Drug Delivery Revenue by Application (2025-2030) & (US$ Million)
Table 209. MEALA Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 210. MEALA Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 211. MEALA Liposome Drug Delivery Sales Price by Application (2019-2024) & (USD/Vial)
Table 212. MEALA Liposome Drug Delivery Sales Price by Application (2025-2030) & (USD/Vial)
Table 213. MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 214. MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 215. MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 216. MEALA Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030) & (K Vial)
Table 217. MEALA Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 218. MEALA Liposome Drug Delivery Sales by Country (2025-2030) & (K Vial)
Table 219. MEALA Liposome Drug Delivery Sales Price by Country (2019-2024) & (USD/Vial)
Table 220. MEALA Liposome Drug Delivery Sales Price by Country (2025-2030) & (USD/Vial)
Table 221. Mexico Liposome Dru
